Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromes. by Goardon, N, Nikolousis, E, Sternberg, A, Chu, W, Craddock, C, Richardson, P, Benson, R, Drayson, M, Standen, G, Vyas, P, Freeman, S

Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia. by Craddock, C, Nagra, S, Peniket, A, Brookes, C, Buckley, L, Nikolousis, E, Duncan, N, Tauro, S, Yin, J, Liakopoulou, E, Kottaridis, P, Snowden, J, Milligan, D, Cook, G, Tholouli, E, Littlewood, T, Peggs, K, Vyas, P, Clark, F, Cook, M, Mackinnon, S, Russell, N

Molecular MRD status and outcome after transplantation in NPM1-mutated AML by Dillon, R, Hills, R, Freeman, S, Potter, N, Jovanovic, J, Ivey, A, Kanda, AS, Runglall, M, Foot, N, Valganon, M, Khwaja, A, Cavenagh, J, Smith, M, Ommen, HB, Overgaard, UM, Dennis, M, Knapper, S, Kaur, H, Taussig, D, Mehta, P, Raj, K, Novitzky-Basso, I, Nikolousis, E, Danby, R, Krishnamurthy, P, Hill, K, Finnegan, D, Alimam, S, Hurst, E, Johnson, P, Khan, A, Salim, R, Craddock, C, Spearing, R, Gilkes, A, Gale, R, Burnett, A, Russell, NH, Grimwade, D